Accelerating the Development of a Universal Influenza Vaccine: A Report from the Sabin-Aspen Vaccine Science and Policy Group

The Sabin-Aspen Vaccine Science & Policy Group convened in 2018 to explore challenges and opportunities to develop a universal influenza vaccine. The group’s recommendations on how to overcome the scientific, financial and organizational barriers to developing a vaccine are synthesized in the report Accelerating the Development of a Universal Influenza Vaccine.

A Decade of Sustainable Immunization Financing

Immunization is among the most impactful and cost-effective health investments a nation can make. However, with the introduction of new vaccines, the cost to vaccinate a child continues to rise. Many low- and middle-income countries that currently receive financial support for their immunization programs will no longer be eligible by 2020 due to their growing economies, and must therefore transition away from external financing and toward country ownership.